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Cell death mechanisms frequently involve the influx of extracellular calcium through voltage- and ligand-gated ion channels, e.g., the
NMDA receptor (Greene, 1999). The vanilloid receptor (VR1 ) is present in regions of the brain (Mezey et al., 2000) that are highly
susceptible to neurodegenerative insults, suggesting that this ion channel might contribute to the cellular processes involved in neuronal
death. We tested the effects of VR1 ligands in the oxygen glucose deprivation (OGD) model of cell death in organotypic hippocampal slice
cultures. The VR1 agonist capsaicin at concentrations that are selective for VR1 did not affect cell viability per se or the extent of
neurodegeneration induced by the OGD insult. In contrast, the VR1 antagonist capsazepine (0.1–10M) significantly reduced the amount
of OGD-induced cell death. However, capsazepine was still neuroprotective in slices prepared from VR1 knock-out mice, which exhibited
the same degree of neurodegeneration to that observed in slices prepared from wild-type mice, excluding the possibility that it afforded
neuroprotection through inhibition of VR1. Instead, capsazepine inhibited the hyperpolarization-activated nonspecific cation channel
generated current Ih in a concentration range similar to that which was neuroprotective. Furthermore, the specific Ih blocker ZD-7288 was
also neuroprotective, mirroring the effects of capsazepine, in that it was effective at preventing cell death when applied either during or
after the OGD insult. These results demonstrate that capsazepine affords neuroprotection through inhibition of Ih rather than inhibition
of VR1.
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Introduction
The cloning of the vanilloid receptor (VR1), concomitant devel-
opment of VR1-selective ligands (i.e., selective agonists, antago-
nists, radioligands, and monoclonal antibodies), and generation
of mice genetically deficient for VR1 have provided a major im-
petus toward the understanding of the physiological functions of
this Ca 2-permeable, nonselective cation channel. In particular,
these approaches have been invaluable in demonstrating that VR1
protein is heavily expressed in sensory neurons and that this
channel plays an important role in sensory nociceptive signaling
(Caterina and Julius, 2001).
However, the more widespread distribution of both VR1
mRNA and protein in areas such as the hippocampus, striatum,
hypothalamus, and cerebellum in both human and rat brain has
suggested additional functional roles for this channel (Sasamura
and Kuraishi, 1999; Hayes et al., 2000; Mezey et al., 2000) in
physiological processes such as satiety, cognition, and motor con-
trol (Szallasi et al., 1995). Such a concept is supported by the
discovery that a number of lipid molecules [e.g., anandamide and
sn-2 arachidonylglycerol (Smart and Jerman, 2000)], which are
present in the CNS and which can be upregulated or downregu-
lated in line with the level of synaptic activity (Stella et al., 1997),
activate VR1. That this channel is permeable to Ca
2 also raises
the possibility that it may be involved in neurodegenerative dis-
ease states. In this respect, both capsaicin and resiniferatoxin el-
evate intracellular free calcium and cause nuclear membrane dis-
ruption and death in cells that express VR1 (Olah et al., 2001;
Grant et al., 2002). Furthermore, alterations in environmental
cues such as acid pH and heat that modulate VR1, and occur in
response to damaging insults to the brain, may exacerbate any
neurodegenerative role that this receptor might play. This is par-
ticularly pertinent to cerebral ischemia in which extracellular
acidification combined with excitatory amino acid release results
in increased anandamide synthesis (Hansen et al., 1995) to levels
that will activate VR1 and lead to proapoptotic injury as described
in a human neuroblastoma cell line (Maccarrone et al., 2000a,b).
Given these observations, we were interested to examine whether
or not VR1 contributes to neuronal cell death in intact neuronal
circuits. The model system we chose to study was oxygen glucose
deprivation (OGD)-induced cell death in organotypic hip-
pocampal slices.
Materials and Methods
All procedures using animal tissues were performed using standard ap-
proved home office protocols.
Autoradiographic binding studies with [3H]resiniferatoxin. Wild-type
/ and VR1 knock-out mice/ [postnatal day 21 (P21)] were killed
by decapitation. The brains were rapidly removed, frozen, stored at
80°C, and subsequently cut into 20 m frozen coronal brain sections.
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The sections were thaw mounted onto gelatin-coated slides and stored at
80°C until time of assay.
After equilibration at room temperature, the sections were incubated
in assay buffer containing the following (in mM): 5 KCl, 5.8 NaCl, 0.75
CaCl2, 2 MgCl2, 320 sucrose, and 10 HEPES, pH 7.4, containing 1 [
3H]
resiniferatoxin ([ 3H]RTX) (specific activity, 30 – 60 Ci/mmol; NEN,
Boston, MA) for 60 min. Nonspecific binding was defined by the addi-
tion of 1 M unlabelled resiniferatoxin.
After incubation, the sections were washed three times for 10 min in
the assay buffer at a temperature of 4°C, briefly dipped into distilled water
at 4°C to remove buffer salts, and allowed to dry in a stream of cool air.
The sections were then apposed to 3H-Hyperfilm for 5 weeks at 4°C.
Adjacent sections to those used for autoradiography were stained with
cresyl fast violet to permit anatomical identification of brain regions.
After exposure, the sections were dipped in LM-1 nuclear emulsion to
permit cellular localization of the [ 3H]resiniferatoxin binding sites. After
15 weeks of exposure to emulsion, the sections were developed and
stained with cresyl fast violet. Images were captured from the autoradio-
graphic film using MCID image analysis software (Interfocus, Cam-
bridge, UK).
Organotypic hippocampal slice culture preparation. Organotypic hip-
pocampal slice cultures were prepared using the method of Stoppini et al.
(1991). Seven- to 8-d-old Sprague Dawley rat pups were killed by cervical
dislocation and decapitated, and the hippocampi were dissected out.
Using a McIlwain tissue chopper, 400-m-thick hippocampal slices were
cut and placed into ice-cold growth medium consisting of 50% mini-
mum essential medium (MEM), 25% HBSS, 25% heat-inactivated horse
serum, 5 mg/ml glucose, and 1 mM glutamine. Slices with complete den-
tate and CA3 and CA1 areas were placed onto semiporous Millicell-CM
inserts (three per membrane) and transferred to six-well plates contain-
ing 1.2 ml of growth medium. Cultures were maintained in 95% air–5%
CO2 at 37°C. Medium was changed every 4 d, and experiments were
performed after 12–14 d in vitro. For mouse cultures, we used the same
protocol as for the rat slice culture preparation, except that P6 pups were
used and experiments were performed after 7–9 d in vitro. The VR1
knock-out mice were prepared as described previously (Davis et al.,
2000).
Oxygen glucose deprivation. For OGD experiments, the culture inserts
were transferred into serum-free medium (SF) with or without com-
pound as appropriate for 1 hr before the insult. They were then placed in
deoxygenated glucose-free medium and sealed under 95% N2–5% CO2
in an anaerobic chamber equilibrated to 37°C and 100% humidity (Ray
et al., 2000). After 40 – 45 min of OGD (mouse organotypics, 35 min),
cultures were removed from the chamber, and the inserts were returned
to serum-free medium saturated with 95% air–5% CO2 containing 6
l/ml propidium iodide (PI). Compound remained present throughout
the duration of the experiment until analysis 23 hr later.
Statistical analysis. OGD-induced cell death was assayed directly in
unfixed cultures using a 5 lens under an inverted microscope (Zeiss,
Oberkochen, Germany) equipped for fluorescence detection. Matching
PI fluorescence and transmitted light images of each whole slice were
recorded, and the amount of cell death in matched control and
compound-treated cultures were analyzed using NIH Image software
(version 1.62). The area of the cell body layer in the hippocampal CA1
area was traced from the bright-field image and superimposed over the PI
image. Results were then expressed as the percentage (mean SEM) of
the total CA1 area expressing PI fluorescence. Statistical analysis was
determined by ANOVA.
Drug application. Stock solutions of compounds were made up in
dimethylsulfoxide (DMSO) (Sigma, St. Louis, MO) at 10 mM. The final
concentration of DMSO for any drug treatment was 0.1%, and control
groups included 0.1% DMSO in all experiments. Before OGD, cultures
were placed in SF containing 75% MEM, 25% HBSS, 5 mg/ml glucose,
and 1 mM glutamine for 1 hr. Compound concentrations were made up
from stock solutions as appropriate.
Electrophysiological recordings. Synaptic activity was recorded using
either whole-cell patch-clamp or extracellular single-electrode or multi-
electrode array (MEA) recording approaches. In all recording configura-
tions, slices were bathed in warmed (32–37°C), perfusing (1– 4 ml/min)
artificial CSF (aCSF) containing the following (in mM): 124 NaCl, 3 KCl,
26 NaHCO3, 1.25 NaH2PO4, 2 CaCl2, 1 MgSO4, and 10 D-glucose (bub-
bled with 95% O2–5% CO2).
Whole-cell patch-clamp recordings were made under visual guidance
using an Olympus Optical (Tokyo, Japan) BX50WI upright microscope.
Microelectrodes (5– 8 M) connected to an Axopatch 200B amplifier
(Axon Instruments, Foster City, CA) were filled with 135 mM
K-gluconate, 10 mM MgCl2, 10 mM HEPES, 2 mM Mg ATP, 1 mM EGTA,
0.3 mM Na GTP, 0.1 mM CaCl2, pH 7.2, 290 –295 mOsm. Series resis-
tances were compensated at 80% with a lag of 8 sec. Cell viability was
assessed throughout the course of experiments via measurement of cell
input resistance. Patch-clamp data were filtered at 5 kHz, digitized at 20
kHz, and stored on a personal compauter hard disk drive for offline analysis
using Minianalysis software and Clampfit 8.2 (Axon Instruments).
Extracellular recordings were made from individual hippocampal sub-
fields using aCSF-filled glass microelectrodes (1–2 M). For evoked re-
sponses, concentric bipolar stimulating electrodes were placed to stimu-
late the Schaffer collaterals at the CA3 to CA1 border, and glass recording
electrodes filled with aCSF were placed in the center of the CA1 stratum
pyramidale. Constant current pulses were applied in 100 A increments
until a maximum response was obtained.
For spontaneous extracellular activity, recordings were made simulta-
neously from all subfields of hippocampal slices using a 64 electrode
planar MEA purchased from MultiChannel Systems (Reutlingen, Ger-
many). A small piece of semiporous membrane bearing the hippocampal
slice was cut out of the culture well using a scalpel blade. This was posi-
tioned slice down onto an MEA, which had been coated previously using
5l of a solution comprising 1 cm 2 cellulose nitrate filter paper dissolved
in 10 ml of methanol. The final orientation of the slice with respect to the
electrodes was achieved with the aid of a Zeiss Stemi SV6 microscope.
The MEA recording chamber was then immediately flooded with 1 ml of
aCSF, and a photographic image was taken of the electrode positions
beneath the hippocampal subfields (DC300 digital camera; Leica, Nuss-
loch, Germany). MEA extracellular recordings were made from all sub-
fields of the slice using the procedures outlined previously (Egert et al.,
1998). MEA data were sampled at 5 kHz, stored on hard disk or CD-R,
and analyzed offline using Multi Channel Systems and pClamp 9 (Axon
Instruments) and Neuroexplorer (Plexon Instruments) software.
Results
Effect of capsaicin on OGD-induced cell death
Recent localization studies demonstrate expression of VR1 im-
munoreactivity and VR1 mRNA in many regions of the rodent
brain, including the cortex and hippocampus (Mezey et al.,
2000). Because VR1 provides a Ca
2 influx pathway that might be
activated in pathophysiological conditions, we hypothesized that
agonists and antagonists of VR1 might have neurotoxic and neu-
roprotective effects, respectively, under conditions of OGD. Be-
fore being subjected to the OGD insult, organotypic hippocam-
pal cultures were grown for 12–14 d and examined for signs of cell
death. The VR1 full agonist capsaicin (10M), applied for 24 hr to
control cultures, produced no toxic effect, as evaluated by the
absence of any change in the low level of PI staining observed in
these untreated slices (data not shown). Likewise, capsaicin (10
M) applied from 1 hr before OGD through the OGD period and
up to the 24 hr post-OGD assessment time point did not affect the
extent of cell death induced by the OGD insult (data not shown).
Effect of capsazepine on OGD-induced cell death
Next we tested the ability of the VR1 antagonist capsazepine to
protect against the OGD insult. Application of capsazepine from
1 hr before and throughout the OGD insult significantly reduced
the magnitude of PI staining measured 24 hr after the OGD insult
(Fig. 1A). This capsazepine-induced neuroprotection was con-
centration dependent. Thus, 100 nM capsazepine reduced CA1
cell death by 34 8%, whereas 10M produced almost complete
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protection (Fig. 1B), potency in line with the activity of capsaz-
epine at rat VR1 (Jerman et al., 2000; McIntyre et al., 2001).
Vehicle controls produced no alteration in OGD-induced PI
staining.
To determine whether the neuroprotection afforded by cap-
sazepine in slice viability experiments corresponded to functional
neuroprotection, we investigated whether capsazepine also re-
versed the electrophysiological deficits induced by the OGD in-
sult. As illustrated in Figure 2, the maximum amplitude of pop-
ulation spikes evoked in stratum pyramidale of area CA1 in
response to stimulation of the Schaffer collateral commissural
pathway was dramatically reduced 24 hr after the OGD insult
compared with that recorded in untreated control slices. In con-
trast, population spikes in slices that were exposed to OGD in the
presence of capsazepine were not significantly different from
control ( p 0.05) (Fig. 2A). This preservation of synaptic activity
was also evident in multi-electrode array recordings in which spon-
taneous activity present in control slices was eliminated in OGD
slices but preserved in slices treated with capsazepine (Fig. 2B).
Post OGD treatment with capsazepine
Although capsazepine afforded clear functional protection of
hippocampal synaptic activity when used as a continuous appli-
cation covering the period from 1 hr before the OGD insult right
up to the 23 hr post-OGD assessment point, we were interested to
ascertain whether more restricted applications also proved neu-
roprotective. To do this, two strategies were used: (1) capsazepine
(10M) was applied just for the period of the OGD insult, and (2)
capsazepine (10 M) was applied starting just after the OGD
insult and continuing up to the 23 hr post-OGD assessment
point. In both experiments, significant neuroprotection was
measured using propidium iodide staining, although the abso-
lute magnitude of protection was slightly lower than that when a
pretreatment drug regimen was used (Fig. 3). Regardless of this,
these data suggest that capsazepine has protective actions both
during the OGD insult and in the period after OGD.
OGD-induced cell death in VR1 knock-out mice
Given that (1) capsazepine has been reported to inhibit a number
of ion channels other than VR1 and (2) the VR1 agonist capsaicin
Figure 1. Concentration-dependant reduction in PI staining by capsazepine in organtypic
brain slices. A, Propidium iodide-stained slice cultures after 45 min OGD imaged at 24 hr after
insult. Control OGD, 100 nM capsazepine, 1M capsazepine, 10M capsazepine. B, Capsazepine
protects hippocampal CA1 neurons from OGD-induced cell death in a concentration-dependent
manner. Data are mean SEM. *p 0.05; ***p 0.0005. DG, Dentate gyrus.
Figure 2. Functional neuroprotection with capsazepine. A, Maximum amplitude population
spikes, recorded in stratum pyramidale of area CA1 using a 3 M NaCl filled microelectrode, from
a control slice (no OGD insult), a slice that has received OGD, and an OGD plus capsazepine (10
M)-treated slice. The bar graph shows pooled data for the peak amplitude of the population
spike evoked in these three populations of slices, with numbers of slices in parentheses. OGD-
treated slices show a reduction in EPSP amplitude, and this is prevented by capsazepine. B,
Extracellular population spike activity recorded from area CA1 of hippocampal organotypic
slices. Three grids show representative 1 sec sweeps from 12 electrodes beneath area CA1. A
single trace is shown below each grid on an enlarged scale. The left shows the level of sponta-
neous activity present in a naive control slice. OGD insult (middle) virtually abolishes all firing,
whereas pretreatment with capsazepine (10M; Cpz) administered 1 hr before OGD affords a
clear preservation of neuronal activity recorded immediately after insult (right).
Figure 3. Capsazepine is still neuroprotective if added after OGD. Capsazepine (10M) was
added to the cultures at three different time points: before OGD for 1 hr, remaining throughout
until analysis at 24 hr ( A), during the OGD phase only ( B), and after OGD only, remaining until
analysis 23 hr later ( C). Results show that there was significant protection in all cases, with the
greatest effect seen with the standard pretreatment. Data are mean SEM. *p 0.05; **p
0.005; ***p 0.0005.
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did not in its own right cause neurotoxicity, it was possible that
capsazepine was having its neuroprotective action through
mechanisms other than VR1 antagonism. To test this hypothesis,
we examined whether genetic elimination of VR1 decreased the
susceptibility of VR1 / (Davis et al., 2000) organotypic hip-
pocampal slices to damage by OGD insult.
Initially, we established that VR1 had been knocked out by
comparing the pattern of [ 3H]RTX binding in VR1 / with
that in VR1 / brain. Autoradiographical analysis using this
radioligand produced a strong signal compared with nonspecific
binding in all neuronal layers of the hippocampus from VR1/
animals (n  3) (Fig. 4A). Examination of the CA1 region at
higher magnification revealed silver grains distributed over stra-
tum pyramidale, oriens, and radiatum (data not shown). In con-
trast, sections of VR1/ tissue showed levels of [
3H]RTX bind-
ing that were little different from nonspecific binding (n  3)
(Fig. 4B). These results confirmed that VR1 protein was widely
distributed in all subfields of the hippocampus and that this was
absent in VR1/ brain.
We next proceeded to explore the functional effects of VR1
ligands on OGD-induced cell death in VR1 / organotypic
hippocampal slices. To do this, we first needed to reduce the
period of OGD in mouse slice cultures to 35 min to match the
level of CA1 neuronal cell death to that produced by 45 min OGD
in rat slice cultures. This aside, it was interesting to establish that
the extent of control damage in VR1/ hippocampal slices was
not significantly different from that in VR1/ slices (84 3 vs
77  3%) (Fig. 4). These data indirectly
increased the possibility that capsazepine
was having its neuroprotective effects
through mechanisms other than VR1
antagonism.
To test this hypothesis, we next exam-
ined whether capsazepine prevented
OGD-induced neuronal cell death in hip-
pocampal slice cultures obtained from
VR1 / mice. As in rat hippocampus,
capsaicin had no effect on OGD-induced
cell death in either VR1/ or VR1/
slices (Fig. 4A,B). However, 10M capsaz-
epine administered from 1 hr before OGD
and throughout the insult until the 23 hr
post-OGD assessment time point afforded
similar levels of neuroprotection in both
VR1 / and VR1 / slice cultures to
that observed in rat hippocampal slices.
Together, these results provide convincing
evidence that VR1-activated cellular pro-
cesses are not involved in OGD-induced
neurodegeneration in the hippocampus
and suggest that the neuroprotective
mechanism of capsazepine operates via
an alternative process to simple blockade
of VR1.
Capsazepine neuroprotection: an action
on other receptors or ion channels?
Given these data, we next examined
whether any of the other pharmacological
actions that have been described for cap-
sazepine could account for its neuropro-
tective effects. In a first series of experi-
ments, we examined whether capsazepine
affected both ionotropic and metabotropic glutamate receptors
(mGluRs) because antagonism of these receptors has been widely
reported to afford functional neuroprotection in vitro. As illus-
trated in Figure 5A, capsazepine had no effect on the frequency or
amplitude of spontaneous AMPA or GABAA receptor-mediated
postsynaptic currents recorded in organotypic slice cultures. Fur-
thermore, capsazepine had no effect on either bicuculline (10
M) induced epileptiform activity (n  6) (Fig. 5B), which is
dependent on activation of both NMDA and AMPA receptors, or
mGluR-dependent synchronized population bursting induced
by application of the group I mGluR agonist (RS)-3,5-
dihydroxyphenylglycine (DHPG) (20M) (frequency of bursting
and peak amplitude of individual bursts in the absence and pres-
ence of capsazepine were 16.2 2.6 and 17.4 1.4 Hz and 208
13 and 205 16 pA, respectively; n 3) (Fig. 5C).
In a second series of experiments, we examined whether cap-
sazepine affected TTX-sensitive voltage-gated sodium channels
in organotypic hippocampal slices because inhibition of these
channels affords complete neuroprotection to OGD. In three ex-
periments, capsazepine did not affect voltage-gated sodium cur-
rents such that the peak amplitude of the Na current in re-
sponse to a 20 mV depolarizing step was 4143 132 pA in control
medium as opposed to 4457 141 pA in the presence of capsaz-
epine (Fig. 5D).
In a third series of experiments, we examined the unlikely
possibility that the well documented antagonism of nicotinic ace-
tylcholine receptors by capsazepine (Liu and Simon, 1997) ac-
Figure 4. Capsazepine is still protective against OGD-induced cell death in VR1 knock-out mice cultures. Distribution of specific
[ 3H]resinferatoxin binding in the brain of VR1 wild-type and knock-out mice (A, B, respectively). Scale bar, 2 mm. Note the large
reduction in binding seen in the knock-out brain compared with the wild type. A, Control damage in VR1/mice is similar to
that in VR1/mice ( B), indicating that VR1 is not required for OGD-induced cell death. Capsaicin has no effect in either VR1
/mice or VR1/mice, whereas capsazepine protects against CA1 damage in cultures from both VR1/and VR1/
mice. ***p 0.0005 (middle graphs). Images on the right show PI staining in slice cultures from either control OGD or OGD and
capsazepine (10M). DG, Dentate gyrus.
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counted for the neuroprotective action of capsazepine. To do
this, we took an alternative approach and examined whether the
selective nicotinic acetylcholine receptor (nAChR) antagonists
-methlylcaconitine (10 M) and dihydro--erythroidine (10
M) affected OGD-induced cell death in rat organotypic hip-
pocampal slices. In every experiment performed, neither antag-
onist affected the magnitude of neuronal cell death induced by
the OGD insult (Fig. 6)
Having exhausted these possible mechanisms as the pathway
by which capsazepine affords neuroprotection, we cast our net of
potential mechanisms much wider by examining the possibility
that capsazepine might inhibit voltage-gated channels related to
VR1. Specifically, we chose to examine whether capsazepine in-
hibited the hyperpolarization-activated nonspecific cationic
channel because this is highly expressed in the hippocampus and
is likely to be involved in synchronization–patterning of neuronal
activity that is believed to occur as a result of the OGD insult.
First, we chose to examine whether capsazepine inhibited the
current (Ih) that is generated in hippocampal neurons when they
are hyperpolarized from 50 to 140 mV for 1 sec. In all neu-
rons tested, capsazepine (10 M) produced a 42.3  2.8% inhi-
bition of Ih (n 3), whereas the specific Ih inhibitor ZD-7288 at
the same concentration afforded a 9.26 5.3% block (n 3).
Given these findings and that capsazepine produced almost
complete inhibition of OGD-induced cell death at 10 M, we
were interested to examine whether ZD-7288 was also able to
prevent OGD-induced cell damage. Application of ZD-7288
from 1 hr before and throughout the OGD insult significantly
reduced the magnitude of PI staining measured 24 hr after the
OGD insult (Fig. 7). This effect was concentration dependent
such that 100 nM ZD-7288 reduced CA1 cell death by 19.14 
4.6%, whereas 1 M produced almost complete protection, with
vehicle controls producing little or no effect. To further charac-
terize this neuroprotective effect of ZD-7288, we examined
whether functional neuroprotection was obtained by investigat-
ing whether this compound also reversed the electrophysiological
deficits induced by the OGD insult. As illustrated in Figure 7,
ZD-7288 significantly reversed the reduction in maximum pop-
ulation spike amplitude that is observed 24 hr after the OGD
insult in untreated control slices.
Although these results closely paralleled those of capsazepine
treatment, we wanted to confirm that ZD-7288 was also capable
of providing neuroprotection when it was applied after the OGD
insult because this was another activity exhibited by capsazepine.
To do this, ZD-7288 (10 M) was applied starting just after the
OGD insult and continuing up to the 23 hr post-OGD assessment
point. As predicted, if capsazepine was affording neuroprotection
through inhibition of Ih, ZD-7288, when applied after the OGD
insult, prevented the increase in propidium iodide staining that
was observed in control slices.
Discussion
In this study, we showed that VR1 protein is abundantly ex-
pressed in the hippocampus and that, in a hippocampal slice
culture model using both rat and mouse organotypic slices, cap-
saicin is not neurotoxic. Capsazepine on the other hand is a po-
tent neuroprotective agent against OGD-induced damage. How-
ever, this neuroprotection is not via an action on VR1. To gain
insight into the mechanism of action of capsazepine, we investi-
gated its actions on other receptors and channels within the slice
Figure 5. Capsazepine does not effect AMPA or NMDA receptor-mediated transmission and
has no effect on voltage-gated sodium channels. A, Traces on the left are whole-cell recordings
of spontaneous EPSCs sampled from a CA1 pyramidal neuron holding at70 mV in control
medium and in the presence of 10M capsazepine (CPZ). Traces on the right are IPSCs sampled
from another CA1 pyramidal neuron under control conditions and in the presence of 10 M
capsazepine. The histograms illustrate the absence of effect of capsazepine (10 M) on the
frequency and amplitude of EPSCs and IPSCs. B, Traces from top to bottom are synchronized
bursts recorded in bicuculline (10M; bic)-containing medium in the added presence of 10M
capsazepine (cpz) and in the added presence of 50M D-AP-5 (AP5). The bar graph below shows
pooled data for six experiments demonstrating no significant effect of capsazepine and a sig-
nificant reduction in burst duration by the NMDA receptor antagonist D-AP-5. C, Traces are taken
from the same experiment illustrating spontaneous EPSCs in A but represent activity in the
presence of 20 M DHPG. Note that DHPG causes a significant increase in the frequency of
postsynaptic currents as well as synchronized bursting activity, neither of which were modified
by capsazepine. D, Voltage-gated sodium channel currents induced by a step from70 to50
mV (duration, 100 msec) are not modified by capsazepine. These traces are averages of five
sweeps each.
Figure 6. Nicotinic receptor antagonists are not neuroprotective against OGD-induced cell
death. Effect of the broad-spectrum nAChR antagonist dihydro--erythroidine (10M; DHE)
and the 7 nAChR-selective antagonist -methlylcaconitine (10 M; MCC) on OGD-induced
cell death in organotypic slice cultures. n 12 each group. Data are mean SEM and normal-
ized to control.
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and discuss further potential targets in which capsazepine may
have an action.
VR1 agonist effects in slice cultures
In our experiments, capsaicin showed no deleterious effects on
either naive slice cultures or cultures exposed to OGD in the
presence of capsaicin. In contrast, in other purely cell-based sys-
tems, agonists of VR1 have induced apoptotic mechanisms result-
ing in cell death (Maccarrone et al., 2000a). This apoptotic cell
death is usually linked to an increase in internal calcium levels
and activation of certain proteases (Chard et al., 1995). The rea-
son for this difference is not clear. One possibility is that, in
organotypic slices, the expression of VR1
on individual neurons may be so low that
any intracellular rise in Ca 2 is easily buff-
ered, by intracellular Ca 2 binding pro-
teins, to a level that is below that which is
neurotoxic. Alternatively, the complex in-
teractions between glia and neurons in or-
ganotypic cultures may conspire together
to attenuate any neurotoxic effect of cap-
saicin by activation of endogenous neuro-
protective cellular processes within the
slice.
Capsazepine is neuroprotective in
slice cultures
Our studies using the OGD model have
shown that capsazepine is neuroprotective
in that it prevents both changes in cell
number and alterations in macroscopic
synaptic function that normally occur in
response to this insult. Taken at face value,
these results could be interpreted as a neu-
roprotective action through antagonism
of the Ca 2-permeable nonspecific cation
channel VR1. However, when viewed in
conjunction with the observation that cap-
sazepine is still neuroprotective in hip-
pocampal slices derived from VR1 knock-
out mice, it appears that capsazepine is
acting through an alternative mecha-
nism(s) to VR1 antagonism to produce its
neuroprotective effect. Furthermore, not
only does VR1 not appear to be an essential
component in OGD neurodegeneration,
its sustained activation does not result in
marked changes in neuronal excitability or
cellular deterioration, because 10 M cap-
saicin, which is sufficient to maximally ac-
tivate VR1 in sensory neurons (Bevan et al.,
1992), had no overt effects on synaptic
electrophysiology or cell viability.
Thus, if the neuroprotective action of
capsazepine does not result from an inter-
action with VR1, how does capsazepine af-
ford neuroprotection? The VR1 receptor,
although clearly unique in its own right,
does share many molecular and biophysi-
cal properties that are displayed by other
members of the voltage-gated and ligand-
gated ion channel families. It is not sur-
prising, therefore, that capsazepine has
been reported to inhibit a variety of ligand- and voltage-gated ion
channels that, like VR1, are cation permeable.
AMPA and NMDA receptors
Antagonism of NMDA receptors has been shown to be extremely
effective in preventing OGD-induced neurodegeneration (Maier
et al., 1995; Werth et al., 1998; Pringle et al., 2000). Likewise,
blockade of AMPA receptors can afford neuroprotection
(Strasser and Fischer, 1995; LoPachin et al., 2001). However,
these are unlikely to be the target mechanisms that explain the
neuroprotective effect of capsazepine because capsazepine did
Figure 7. Capsazepine inhibits Ih, and the specific Ih blocker ZD-7288 is neuroprotective against OGD-induced cell death. A,
Sample traces from whole-cell patch-clamp recordings of hyperpolarized activated cation current. Left shows the significant
inhibitory effect of capsazepine, and the right shows near-complete block of the current by the specific Ih blocker ZD-7288. In each
panel, responses in the presence of CsCl, which abolishes the current, are included as a reference. B, PI images of organotypic
hippocampal slice cultures treated with vehicle (Control), ZD-7288 (1M), or MK-801 (positive control) (10M). Compound was
given either 1 hr before OGD or immediately after OGD. Images were taken 24 hr after insult. C, Dose–response data for ZD-7288.
*p 0.05; ***p 0.0005. Data are mean SEM and normalized to control. D, Typical field EPSPs recorded in the CA1 region of
the hippocampus. The presence of ZD-7288 substantially reversed the reduction in amplitude of responses in slices subjected
to OGD.
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not affect AMPA or NMDA receptor-mediated synaptic trans-
mission. The inactivity of capsazepine as a group I mGluR antag-
onist is also noteworthy because both mGluR1 and mGluR5 an-
tagonists have been shown recently to prevent excitotoxic
neurodegeneration (Bruno et al., 1999, 2000).
Sodium and potassium channels
Capsazepine inhibits both voltage-gated sodium and potassium
channels (Kuenzi and Dale, 1996; Su et al., 1999). However, these
nonspecific actions are observed at concentrations in excess of 10
M, which are 10- to 100-fold higher than the concentrations that
afford significant levels of neuroprotection in the present study.
Furthermore, we could not demonstrate any effect of capsazepine
on TTX-sensitive voltage-gated sodium currents in our hip-
pocampal organotypic slice cultures. Thus, it seems unlikely that
modification of these cationic channels is a major contributing
factor to the neuroprotective mechanisms invoked by capsaz-
epine in the OGD model.
Voltage-operated calcium channels
Because the magnitude of OGD neurodegeneration is dependent
on extracellular calcium, it is possible that inhibition of voltage-
gated Ca 2 channels could potentially provide a mechanism of
neuroprotection. However, although capsazepine has been re-
ported to inhibit voltage-activated calcium channels (Docherty et
al., 1997), it is unlikely that this activity is responsible for its
neuroprotective action because (1) the IC50 for capsazepine in-
duced voltage-gated Ca 2 channel blockade is 1.4 –10 M,
whereas the IC50 for its neuroprotective effect is 0.1– 0.3 M, and
(2) studies using the high-voltage-activated calcium channel an-
tagonists -conotoxin MVIIC, which blocks N type as well as
other presynaptic calcium channels, nifedipine, which blocks L
type channels, and SB201823-A, which is a broad-spectrum cal-
cium channel blocker, provided little or no protection against
OGD insults in organotypic hippocampal cultures (Pringle et al.,
1996).
Nicotinic acetylcholine receptor
Nonglutamatergic ligand-gated ion channels have also been im-
plicated as targets affording neuroprotection. One in particular is
the nAChR (Marin et al., 1994). However, although capsazepine
has been shown to be active against this ligand-gated receptor, it
acts as an antagonist (Liu and Simon, 1997), and it is generally
accepted that nicotinic agonists, and not antagonists, afford neu-
roprotection (Dajas-Bailador et al., 2000). Furthermore, in our
own studies, we showed that the broad-spectrum nAChR antag-
onist dihydro--erythroidine and the7 nAChR-selective antag-
onist -methylcaconitine suggest that antagonism of nAChRs
does not protect against OGD-induced neurodegeneration.
Hyperpolarization activated cyclic nucleotide modulated
channel-1 channels
An interesting and novel finding of this study, however, was that
capsazepine inhibited the hyperpolarization-activated nonspe-
cific cation channel-mediated current Ih. We believe that it is this
activity that underlies the neuroprotective effects of capsazepine
because (1) the concentration range over which capsazepine in-
hibited Ih was similar to that which afforded functional neuro-
protection, and (2) the specific Ih blocker ZD-7288 exhibited a
very similar profile of neuroprotection to that afforded by cap-
sazepine in that it prevented cell death when applied either before
or after the OGD insult. Recently, the specificity of ZD-7288 as a
selective Ih blocker has been called into question (Chevaleyre and
Castillo, 2002). However, in the current study, we are confident
that its effects are related to inhibition of Ih because it was
effective in a concentration range that inhibits Ih, and, equally
importantly, this range is well below that reported to inhibit
glutamatergic synaptic transmission. That inhibition of Ih is
neuroprotective can be rationalized by the well documented
observations that ZD-7288 hyperpolarizes hippocampal neurons
and prevents concerted synchronized bursting of the form likely
to produce neuronal damage.
Concluding remarks
Given the data presented in this study that rule out previously
identified pharmacological activities of capsazepine as the site of
action of its neuroprotective activity, we feel that it is justified to
conclude that capsazepine mediates its neuroprotective effects, at
least in part, through inhibition of Ih. That said, we cannot con-
clusively rule out the possibility that it may mediate part of its
effects through (1) conjoint activation and/or inhibition of a
number of cellular processes or (2) additional pharmacological
properties yet to be discovered, e.g., block of an, as yet, undis-
closed voltage-gated channel and possibly a member of the
transient receptor potential channel family to which VR1 and
hyperpolarization activated cyclic nucleotide modulated
channel-1 channels are closely related (Caterina et al., 1997). This
aside, that inhibition of Ih provides neuroprotection is a particu-
larly novel and interesting finding, not least because this mecha-
nism is effectively neuroprotective when implemented either be-
fore or after the OGD insult. Most importantly, this pattern of
activity is what is required to produce a useful therapeutic agent
for stroke and other head trauma injuries as these patient groups
are usually defined after the initial neurodegenerative insult when
treatment is restricted to preventing the secondary damage that
occurs after that induced by the insult itself.
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